Healthcare -
Biotechnology - NASDAQ - US
$ 493.756
-0.384 %
$ 52.4 B
Market Cap
12.27
P/E
REGN - GROSS PROFIT
Gross Profit REGN - Regeneron Pharmaceuticals, Inc.
12.2 B
LAST VALUE
7.36%
2 YEAR CAGR
11.55%
5 YEAR CAGR
16.68%
10 YEAR CAGR